Free Trial

Immunovant (IMVT) Insider Trading & Ownership

$29.26
+0.09 (+0.31%)
(As of 10/17/2024 ET)

Immunovant (NASDAQ:IMVT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.90%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
7
Amount Of
Insider Selling
(Last 12 Months)
$5.72 M
Get IMVT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Immunovant stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

IMVT Insider Buying and Selling by Quarter

Immunovant Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/9/2024Eva Renee BarnettCFOSell5,162$29.56$152,588.72  
10/9/2024Peter SalzmannCEOSell4,460$29.56$131,837.60  
7/24/2024Jay S StoutCTOSell2,813$27.76$78,088.88  
7/24/2024Michael GeffnerInsiderSell3,456$27.76$95,938.56  
7/17/2024Eva Renee BarnettCFOSell3,123$29.69$92,721.87  
7/17/2024Mark S LevineInsiderSell2,505$29.69$74,373.45  
7/17/2024Peter SalzmannCEOSell8,685$29.69$257,857.65  
7/9/2024Eva Renee BarnettCFOSell4,747$28.06$133,200.82  
7/9/2024Julia G ButchkoInsiderSell1,527$28.06$42,847.62  
7/9/2024Peter SalzmannCEOSell4,619$28.06$129,609.14  
5/22/2024Eva Renee BarnettCFOSell4,042$29.65$119,845.30  
5/22/2024Julia G ButchkoInsiderSell3,247$29.65$96,273.55  
5/22/2024Peter SalzmannCEOSell16,163$29.65$479,232.95  
4/24/2024Jay S StoutCTOSell7,239$28.90$209,207.10  
4/24/2024Michael GeffnerInsiderSell3,261$28.90$94,242.90  
4/17/2024Eva Renee BarnettCFOSell12,253$29.06$356,072.18  
4/17/2024Julia G ButchkoInsiderSell10,115$29.06$293,941.90  
4/17/2024Peter SalzmannCEOSell34,079$29.06$990,335.74  
4/9/2024Eva Renee BarnettCFOSell3,689$31.18$115,023.02  
4/9/2024Julia G ButchkoInsiderSell1,053$31.18$32,832.54  
4/9/2024Peter SalzmannCEOSell4,807$31.18$149,882.26  
2/22/2024Eva Renee BarnettCFOSell2,930$36.15$105,919.50  
2/22/2024Mark S LevineInsiderSell2,134$36.15$77,144.10  
1/26/2024Mark S LevineInsiderSell3,027$37.92$114,783.84  
1/18/2024William L MaciasInsiderSell424$41.03$17,396.72  
1/11/2024Eva Renee BarnettCFOSell3,515$41.83$147,032.45  
1/5/2024Julia G ButchkoInsiderSell1,297$38.59$50,051.23  
1/5/2024Peter SalzmannCEOSell3,824$38.59$147,568.16  
11/22/2023Eva Renee BarnettCFOSell4,055$32.78$132,922.90  
11/22/2023Julia G ButchkoInsiderSell3,265$32.78$107,026.70  
11/22/2023Peter SalzmannCEOSell16,217$32.78$531,593.26  
10/25/2023Mark S LevineInsiderSell4,107$34.66$142,348.62  
10/19/2023William L MaciasInsiderSell530$36.80$19,504.00  
(Data available from 1/1/2013 forward)

IMVT Insider Trading Activity - Frequently Asked Questions

5.90% of Immunovant stock is owned by insiders. Learn more on IMVT's insider holdings.

The following insider purchased IMVT shares in the last 24 months: Sciences Ltd. Roivant ($58,000,008.00).

Insiders have purchased a total of 1,526,316 IMVT shares in the last 24 months for a total of $58,000,008.00 bought.

The following insiders have sold IMVT shares in the last 24 months: Eva Renee Barnett ($2,011,380.21), Jay S Stout ($287,295.98), Julia G Butchko ($1,754,057.02), Mark S Levine ($930,768.08), Michael Geffner ($190,181.46), Peter Salzmann ($8,850,721.97), and William L Macias ($68,909.12).

Insiders have sold a total of 586,441 Immunovant shares in the last 24 months for a total of $14,093,313.84 sold.



This page (NASDAQ:IMVT) was last updated on 10/17/2024 by MarketBeat.com Staff
From Our Partners